4507 (4507) News
Follow 4507 (4507) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Shionogi to Acquire IntraBio for $2 Billion
Shionogi has agreed to acquire U.S.-based drugmaker IntraBio for $2 billion to strengthen its rare disease pipeline.
EQUITY | Oct 05, 2026, 07:14 AM UTC
M
Shionogi to Acquire Intrabio Inc. for Rare Disease Expansion
Shionogi & Co., Ltd. announced its planned acquisition of Intrabio Inc. as part of its ongoing expansion in the rare disease sector.
EQUITY | Oct 05, 2026, 06:29 AM UTC
M
Shionogi to acquire global rights for Aqneursa
Shionogi will acquire the global rights for Aqneursa through a transaction.
EQUITY | Oct 05, 2026, 06:24 AM UTC
L
Shionogi's Earnings Likely to Be Driven by HIV Royalties — Market Talk
Shionogi's earnings are likely to be driven by HIV royalties, Jefferies analysts say in a note. Given that its joint-venture partner GSK has raised its HIV sales guidance, the U.S. bank expects the trend of strong HIV ro
EARNINGS | Sep 07, 2026, 03:33 AM UTC
L
Shionogi announces U.S. government procurement of Fetroja via BARDA
Shionogi & Co., Ltd. announced U.S. government procurement of Fetroja (cefiderocol) through BARDA’s Project Bioshield.
EQUITY | Aug 28, 2026, 12:09 AM UTC